Revolutionary New Carbon-Based Material Captures and Destroys Coronavirus
By HospiMedica International staff writers Posted on 07 May 2020 |

Image: Revolutionary new carbon-based material captures and destroys coronavirus (Photo courtesy of Tortech Nano-Fibers)
A revolutionary new carbon-based material developed by scientists and engineers can capture and destroy an animal coronavirus, a close relative of the SARS-CoV-2 virus that causes COVID-19.
According to a report by Cambridge Independent, the material was developed by a team of researchers from the University of Cambridge (Cambridge, UK) in collaboration with Tortech Nano-Fibers (Ma'alot-Tarshiha, Israel). In the UK, the project team is led by Q-Flo which is delivering an Innovate UK-funded grant, while in Israel, the development and manufacturing efforts are being led by Meir Hefetz, Tortech CTO.
The ‘active virus filter’, in the form of a thin carbon nanotube mat named TorStran has filtration and air permeability properties which allow it to capture free virus molecules and those contained in airborne aerosolized droplets. Both filtration and virus disruption take place simultaneously, thus allowing the filter to reduce the risk of infection by removing contamination from the air. The researchers believe that the filter will be particularly useful in confined situations such as emergency vehicles, hospitals, transportation, waiting areas and wards.
“The original objective of the process was to make ultra-strong conductive fibres for a wide range of applications,” said Prof Alan Windle FRS, one of the original inventors of the process to make the nanotube material at the University of Cambridge. “The fact that the nanotubes compressed into an otherwise randomly oriented mat makes an excellent filter for virus-bearing airborne particles of moisture are suddenly very important as the world faces its current Covid-19 crisis.”
“Our teams in Israel and the UK, including colleagues at Cambridge University, have worked flat out over the past few weeks to demonstrate the effectiveness of the TorStran active virus filter in catching and ‘killing’ the virus. We are looking for partners who can work with us and move at speed to bring Active Virus Filter units into service,” said Dr. Shuki Yeshurun, joint CEO of Q-Flo and Tortech.
Related Links:
University of Cambridge
Tortech Nano-Fibers
According to a report by Cambridge Independent, the material was developed by a team of researchers from the University of Cambridge (Cambridge, UK) in collaboration with Tortech Nano-Fibers (Ma'alot-Tarshiha, Israel). In the UK, the project team is led by Q-Flo which is delivering an Innovate UK-funded grant, while in Israel, the development and manufacturing efforts are being led by Meir Hefetz, Tortech CTO.
The ‘active virus filter’, in the form of a thin carbon nanotube mat named TorStran has filtration and air permeability properties which allow it to capture free virus molecules and those contained in airborne aerosolized droplets. Both filtration and virus disruption take place simultaneously, thus allowing the filter to reduce the risk of infection by removing contamination from the air. The researchers believe that the filter will be particularly useful in confined situations such as emergency vehicles, hospitals, transportation, waiting areas and wards.
“The original objective of the process was to make ultra-strong conductive fibres for a wide range of applications,” said Prof Alan Windle FRS, one of the original inventors of the process to make the nanotube material at the University of Cambridge. “The fact that the nanotubes compressed into an otherwise randomly oriented mat makes an excellent filter for virus-bearing airborne particles of moisture are suddenly very important as the world faces its current Covid-19 crisis.”
“Our teams in Israel and the UK, including colleagues at Cambridge University, have worked flat out over the past few weeks to demonstrate the effectiveness of the TorStran active virus filter in catching and ‘killing’ the virus. We are looking for partners who can work with us and move at speed to bring Active Virus Filter units into service,” said Dr. Shuki Yeshurun, joint CEO of Q-Flo and Tortech.
Related Links:
University of Cambridge
Tortech Nano-Fibers
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Critical Care
view channel
AI Model Analyzes Patient Data to Diagnose Multiple Sclerosis With 90% Accuracy
Multiple sclerosis (MS) is a chronic inflammatory condition affecting the central nervous system. Most patients initially experience the relapsing-remitting form (RRMS), characterized by periods of symptom... Read more
Magnetically Navigable Microparticles Enable Targeted Drug Delivery
Abdominal aortic aneurysms (AAA) can be life-threatening if not treated and result in nearly 10,000 deaths annually. Researchers working to improve treatments for AAA could now make it possible for doctors... Read more
AI-Powered Algorithm Automates Analysis of Coronary Stents After Implantation
Every year, over three million people globally receive stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after stent implantation remains a significant challenge.... Read moreSurgical Techniques
view channel
DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more